Market report
Oncology drug tenders in Portugal — market report, June 2025
Oncology drug tenders in Portugal in June 2025: 116 tenders published (-57% month on month, -15% year on year), estimated at €17,782,872 in total, and 123 contracts awarded (+5% month on month, +43% year on year), worth €997,634 (awarded value). Buyers with the most tenders: Unidade Local de Saúde de Santa Maria, E. P. E. (52), Unidade Local de Saúde Póvoa de Varzim/Vila do Conde, E. P. E. (8) and Unidade Local de Saúde de Viseu Dão-Lafões, E. P. E. (7); most contracts won: Generis – Farmaceutica, S.A. (8), Ipsen Portugal-Produtos Farmacêuticos Sa. (5) and Gilead Sciences Lda. (4). On average 8.5 bids per contract; 15% of contracts had a single bid. Report made on 27 October 2026.
- Tenders published
- 116
- Contracts awarded
- 123
- Contract value awarded
- €997,634
- Bids per contract
- 8.5
The highlighted bar is June 2025. Hover a bar for its figure; the table below has every value.
| Figure | June 2025 | May 2025 | Change | June 2024 | Change |
|---|---|---|---|---|---|
| Tenders published | 116 | 271 | -57% | 136 | -15% |
| Estimated value | €17,782,872 | €10,017,547 | +78% | €35,468,926 | -50% |
| Buyers | 20 | 27 | -26% | 23 | -13% |
| Contracts awarded | 123 | 117 | +5% | 86 | +43% |
| Contract value (awarded) | €997,634 | €3,123,356 | -68% | — | — |
| Winners | 44 | 41 | +7% | 29 | +52% |
| Bids per contract | 8.5 | 15.6 | — | 27.8 | — |
| Single-bid contracts | 15% | 25% | — | 3% | — |
Buyers with the most tenders
Companies with the most contracts
Where the tenders were
Procedures
The report's aggregates: the figures, the comparisons and the top lists by name and count.
All reports: Oncology and immunomodulating drugs
Questions and answers
- How many oncology drug tenders were published in Portugal in June 2025?
- 116 (by 20 buyers); for comparison, May 2025: 271, June 2024: 136.
- Who won the most oncology drug tenders in Portugal in June 2025?
- By number of contracts: Generis – Farmaceutica, S.A. (8), Ipsen Portugal-Produtos Farmacêuticos Sa. (5), Gilead Sciences Lda. (4), Fresenius Kabi Pharma Portugal (4) and Astrazeneca-Produtos Farmacêuticos,lda. (3); 44 companies won contracts in all.
- Which buyers published the most oncology drug tenders in June 2025?
- Unidade Local de Saúde de Santa Maria, E. P. E. (52), Unidade Local de Saúde Póvoa de Varzim/Vila do Conde, E. P. E. (8), Unidade Local de Saúde de Viseu Dão-Lafões, E. P. E. (7), Unidade Local de Saúde da Cova da Beira, E. P. E. (5) and Instituto Português de Oncologia do Porto Francisco Gentil, E. P. E. (5).
- How competitive were oncology drug tenders in Portugal in June 2025?
- On average 8.5 bids per contract (61 contracts with a known number of bids); 15% of contracts had a single bid.
- What were the contracts worth in June 2025?
- €997,634 (awarded value, 123 contracts); median about €6,900.
How the report is made
Tenders published: the tenders of the sector or topic whose first notice is dated in the month (a tender counts in its sector and in up to three topics). Contracts awarded: the awards dated in the month, whenever their tender was published. Values in EUR, by value kind (never added together); medians are approximate (±3 %). Comparisons: with the reports of the previous month and of the same month a year earlier, each made the same way. The report was made on 27 October 2026 from the data of that day and is not changed afterwards; sources publish late, so later data for the month are not in it.